Enhancement of dissolution rate and bioavailability of sulfamethoxazole by complexation with β-cyclodextrin

Drug Development and Industrial Pharmacy

Volumn 38, Issue 3, 2012, Pages 331-340

  Özdemir, Nurten ^a   Erkin, Jlide ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Cyclodextrin; Bioavailability; Coprecipitation method; Kneading method; Sulfamethoxazole

Indexed keywords

BETA CYCLODEXTRIN; MACROGOL 20000; POLYSORBATE 20; SULFAMETHOXAZOLE;

ADULT; ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; HUMAN; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; NORMAL HUMAN;

ADULT; ANTI-INFECTIVE AGENTS; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; HUMANS; MALE; MIDDLE AGED; SOLUBILITY; SPECTROPHOTOMETRY, INFRARED; SULFAMETHOXAZOLE; TIME FACTORS;

EID: 84856454852     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.604327     Document Type: Article

References (25)

1. Martindale, the extra pharmacopoeia.; (1993). 30th Edn. Reynold J.E.F. (ed.), Pharmaceutical Press London, England, p. 208.
2. Raja GV, Sekaran CB, Teja DW, Madhuri B, Jayasree B. (2009). Simple spectrophotometric methods for the determination of sulfamethoxazole in pharmaceuticals using folinciocalteau and orcinol as reagents. Journal of Chemistry, 6:357-360.
3. Bekers O, U?jtendaal EV, Be?jnen JH, Bult A, Undrberg WJM. (1991). Cyclodextrins in the pharmaceutical field. Drug Dev Ind Pharm, 17:1503-1549.
4. Uekama K. (2004). Design and evaluation of cyclodextrin-based drug formulation. Chem Pharm Bull, 52:900-915. (Pubitemid 41701863)
5. Fromming VK, Szejtli J. (1994). Cyclodextrins in Pharmacy Dordrehcht, Kluwer Academic Publishers.
6. Szejtli J. (1988). Cyclodextrin Technology, Dordrecht: Kluwer Academic Publishers.
7. Sinha VR, Anitha R, Ghosh S, Amita, Kumria R, Bhinge JR et al. (2007). Physicochemical characterization and in vitro dissolution behaviour of celecoxib-beta-cyclodextrin inclusion complexes. Acta Pharm, 57:47-60. (Pubitemid 46361947)
8. Loftsson T, Fridr?ksdott?r H, Olafsdott?r BJ. (1991). Solubilization and stabilization of drugs through cyclodextrin complexation. Acta Pharm Nord, 3:215-217.
9. Loftsson T, Fridr?ksdott?r H, Thor?sdottir S, Stefansson E. (1994). The effect of hydroxypropyl methylcellulose on the release of dexamethasone from aqueous 2-hydroxypropyl-cyclodextrin formulations. Int J Pharm, 104:181-184. (Pubitemid 24073703)
10. Loftsson T, Gu?mundsdottir TK, Fridr?ksdott?r H. (1996). The influence of water soluble polymers and pH on hydoxypropyl- -cyclodextrin complexation of drugs. Drug Dev Ind Pharm, 22:401-405. (Pubitemid 26171574)
11. Hirlekar RS, Sonawane SN, Kadam VJ. (2009). Studies on the effect of water-soluble polymers on drug-cyclodextrin complex solubility. AAPS Pharm Sci Tech, 10:858-863.
12. Elgindy N, Elkhodainy K, Molokhia A, Elzoghby A. (2011). Lyophilized flutamide dispersions with polyols and amino acids: Preparation and in vitro evaluation. Drug Dev Ind Pharm, 37:446-455.
13. Polonisamy M, Khonam J. (2011). Solid dispersion of prednisolone: Solid state characterization and improvement of dissolution profile. Drug Dev Ind Pharm, 37:373-386.
14. Patel SG, Rajput SJ. (2009). Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes. AAPS Pharm Sci Tech, 10:660-669.
15. Wang S, Ding Y, Yao Y. (2009). Inclusion complexes of fluorofenidone with beta- cyclodextrin and hydroxypropyl-beta-cyclodextrin. Drug Dev Ind Pharm, 35:808-813.
16. Özdemir N, Ordu S. (1998). Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin. Drug Dev Ind Pharm, 24:19-25. (Pubitemid 28080834)
17. Dhanaraju MD, Kumaran KS, Baskaran T, Moorthy MS. (1998). Enhancement of bioavailability of griseofulvin by its complexation with beta-cyclodextrin. Drug Dev Ind Pharm, 24:583-587. (Pubitemid 28273129)
18. Shargel L, Andrew BC. (1985). Applied Biopharmaceutics and Pharmacokinetics, Norwalk, Connecticut, USA Appleton-Century Crofts.
19. Bratton AC, Marshall EK. (1939). A new coupling component for sulphanilamide determination. J Biol Chem, 128:537.
20. A?abeyolu I., Kaynar-Özdemir N. (1989). Studies on sustained release XII: performance of sulfamethizole granules employing hydrogenated castor oil. 49th International Congress of Pharmaceutical Sciences of F.I.P. Munich, Germany. 127.
21. Loftsson T, Duchêne D. (2007). Cyclodextrins and their pharmaceutical applications. Int J Pharm, 329:1-11. (Pubitemid 44937538)
22. Higuchi T, Connors KA. (1965). Phase solubility techniques. Adv Anal Chem Instrum, 4:117-149.
23. Connors KA, Mollica JA Jr. (1966). Theoretical analysis of comparative studies of complex formation. J Pharm Sci, 55:772-780.
24. Challa R, Ahuja A, Ali J, Khar RK. (2005). Cyclodextrins in drug delivery: An updated review. AAPS Pharm Sci Tech, 6:329-350.
25. The United States Pharmacopeia. (USP XXII). (1990). United States Pharmacopeial Convention Inc. 1260, Twinbrook Parkway Rockwille, MD 20852.